公司资料
ASLAN Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- ASLN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Singapore and listed in the U
股价为何变动
Current closing-price context is not available for ASLN.
公司概览
业务概览
ASLAN Pharmaceuticals is a specialty biopharmaceutical company focused on dermatology and immunology. Its story centers on developing and commercializing therapies for inflammatory skin disease.
所在地与行业分类
ASLAN is headquartered in Singapore and listed in the U.S. market. It sits in specialty dermatology biopharma.
商业模式特征
The company depends on clinical and commercial execution, plus capital discipline across a narrow portfolio. Investors watch product adoption, development milestones, and strategic changes.
生物医药行业定位
ASLAN occupies a niche dermatology-immunology position within biotech. It is a focused specialty story where launch and data execution are central to the stock.
未来催化剂
- ASLAN’s catalysts are varlitinib / oncology programs and any strategic step that clarifies the company’s future after the pipeline reset. The market is watching for a cleaner path forward.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。